Sep 05, 2017 10:00 am UTC| Business
• Verity Health System to assume the professional responsibilities of Breastlink in Southern California as part of an integrated care model• RadNet, with seven million patient visits annually, and Verity Health will...
Cenovus reaches agreement to sell Pelican Lake assets for approximately $1 billion
Sep 05, 2017 10:00 am UTC| Business
CALGARY, Alberta, Sept. 05, 2017 -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) has entered into a definitive agreement to sell its Pelican Lake heavy oil operations, as well as other miscellaneous assets in northern...
Isodiol International Inc. Announces Launching Phytoceutical Division
Sep 05, 2017 10:00 am UTC| Business
VANCOUVER, British Columbia, Sept. 05, 2017 -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical...
Collegium Announces Scientific Presentations at PAINWeek 2017 Meeting
Sep 05, 2017 10:00 am UTC| Business
CANTON, Mass., Sept. 05, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present data on Xtampza® ER, an extended-release oral formulation of oxycodone with abuse-deterrent properties,...
BioCryst Announces Positive Results from its APeX-1 Phase 2 Trial in HAE
Sep 05, 2017 10:00 am UTC| Business
73% Reduction in Overall Attack Frequency at 125mg Dose (p0.001) FDA and EMA Meetings Planned for Fourth Quarter 2017 to Finalize Phase 3 RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2017 -- BioCryst Pharmaceuticals, Inc....
Gulfport Energy Corporation Provides SCOOP Well Results
Sep 05, 2017 10:00 am UTC| Business
OKLAHOMA CITY, Sept. 05, 2017 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today provided an update on recent SCOOP well results. Key highlights include: Pauline 8-27X22H produced at a...
Sep 05, 2017 10:00 am UTC| Business
EDISON, N.J., Sept. 05, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today it will be...